Man Group’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $377K | Sell |
154,683
-371,423
| -71% | -$744K | ﹤0.01% | 2153 |
|
|
2025
Q4 | $721K | Buy |
526,106
+244,054
| +87% | +$322K | ﹤0.01% | 1781 |
|
|
2025
Q3 | $350K | Buy |
282,052
+7,368
| +3% | +$8.78K | ﹤0.01% | 1960 |
|
|
2025
Q2 | $310K | Buy |
274,684
+88,588
| +48% | +$118K | ﹤0.01% | 1953 |
|
|
2025
Q1 | $272K | Buy |
+186,096
| New | +$351K | ﹤0.01% | 1961 |
|
|
2024
Q1 | – | Sell |
-13,800
| Closed | -$44.3K | – | 2106 |
|
|
2023
Q4 | $44.3K | Buy |
+13,800
| New | +$39.1K | ﹤0.01% | 2012 |
|
|
2023
Q3 | – | Sell |
-220,307
| Closed | -$965K | – | 1691 |
|
|
2023
Q2 | $1.09M | Buy |
+220,307
| New | +$1.19M | ﹤0.01% | 1365 |
|
|
2022
Q1 | – | Sell |
-48,576
| Closed | -$725K | – | 2170 |
|
|
2021
Q4 | $725K | Sell |
48,576
-3,996
| -8% | -$70.5K | ﹤0.01% | 1422 |
|
|
2021
Q3 | $1.35M | Buy |
+52,572
| New | +$1.25M | ﹤0.01% | 1279 |
|
|
2021
Q2 | – | Sell |
-54,202
| Closed | -$1.91M | – | 1940 |
|
|
2021
Q1 | $1.91M | Sell |
54,202
-49,404
| -48% | -$1.67M | 0.01% | 1121 |
|
|
2020
Q4 | $2.62M | Sell |
103,606
-17,776
| -15% | -$579K | 0.01% | 1100 |
|
|
2020
Q3 | $4.58M | Buy |
121,382
+6,835
| +6% | +$258K | 0.02% | 861 |
|
|
2020
Q2 | $4.91M | Sell |
114,547
-25,942
| -18% | -$938K | 0.02% | 669 |
|
|
2020
Q1 | $2.73M | Buy |
140,489
+89,722
| +177% | +$2.14M | 0.02% | 747 |
|
|
2019
Q4 | $1.32M | Buy |
+50,767
| New | +$1.4M | ﹤0.01% | 1437 |
|
|
2019
Q3 | – | Sell |
-15,181
| Closed | -$408K | – | 1768 |
|
|
2019
Q2 | $408K | Sell |
15,181
-18,619
| -55% | -$519K | ﹤0.01% | 1705 |
|
|
2019
Q1 | $977K | Buy |
+33,800
| New | +$981K | ﹤0.01% | 1587 |
|
Other funds holding ALLO
P
TGA
VCM
